Roadmap Released
2016 National Research Infrastructure Roadmap has been re;leased by the Federal Government.
Showing 21 - 40 of 74 results
2016 National Research Infrastructure Roadmap has been re;leased by the Federal Government.
Using the OPAL multipurpose reactor,, ANSTO can provide a diverse suite of radioisotopes for research and applications
Our experienced team of engineers, metallurgists, chemists and scientists have a proven track record of working with our clients in Australia and around the world to design and evaluate novel flowsheets and improve established processes.
Choose from our list of research topics and let your students lead a 30 minute Q&A session with our ANSTO experts.
ANSTO provides nuclear forensic analysis and advice in support of law enforcement and training to domestic and international partners
The ANSTO Innovation Series is a live and virtual meet-up that focuses on the key capacities of ANSTO’s people, partners and facilities and how they are meeting global challenges in sustainable industries, medicine, advanced manufacturing and in accelerating small business.
Defence requirements push your technology, we can help. ANSTO is home to some of Australia’s most important landmark research infrastructure – more than $1.3bn of it. Our unique capabilities are used by thousands of Australian researchers from industry and academia every year.
The measurement and manipulation of radiation and radioactive materials within biological systems. Capabilities include access to a range of radioisotopes, gamma/X-ray sources and a selection of X-ray beams, ion beams and neutron beams for irradiation.
The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.
ANSTO has made two public submissions to parliamentary inquiries with another to be submitted in February 2020 on matters relating to nuclear technologies, their peaceful applications, and the nuclear fuel cycle.
Twenty-four participants from Asia and the Pacific travelled to ANSTO for an International Atomic Energy Agency Regional Training Course on ‘Production and preclinical evaluation of emerging cyclotron-based radiopharmaceuticals’
Combining resources and expertise to address climate change in the Asia-Pacific
Research and development activity explores new, boutique radioisotopes, including positron, gamma and beta/gamma emitter. The aim is to provide material for the next generation of diagnostic and therapeutic radiopharmaceuticals
Accelerator Mass Spectrometry (AMS) is an ultra-sensitive analytical technique based on the use of an ion accelerator as a powerful mass spectrometer.
Neutron Activation Analysis (NAA) is a highly sensitive method of quantitative elemental analysis. There is a wide range of potential applications for neutron irradiations.
In May 2023, The Honourable Dr Annabelle Bennett, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry, Science and Technology.
When an energetic ion beam hits a sample it will interact with the atoms through a number of very complex interactions. By detecting and measuring the reaction products resulting from the various interactions and their intensities, you can obtain quantitative data on the sample's constituent elements and their spatial distribution.